Deramaxx® is a non-steroidal anti-inflammatory
(NSAID) marketed by Novartis Animal Health Products. The
essence of the Novartis marketing campaign is that because
Deramaxx® is a Cox-2 specific NSAID it is both safer
and more effective than other veterinary NSAIDs. Claims
like this have been disallowed by the Food and Drug Administration
for human Cox-2 inhibitors. Cox-2 inihibitors simply trade
one set of side effects for another.
As with any NSAID, it is a medicine to
be taken wisely since the side effects can include death.
As of February 24, 2003, the Center for
Veterinary Medicine of the Food and Drug Administration
had received reports of the death of 27 dogs which were
possibly linked to Deramaxx®. Reported adverse events
typically represent about 10%-15% of actual events.
This website has been created to provide
information on using Deramaxx® intelligently and dealing
with problems should they arise.
Deramaxx® Information
Overview
Prescribing
Information
Dealing
with Adverse Reactions
Reporting
an Adverse Event
Scientific
Studies
Adverse
Event Statistics
Questions,
Comments, Suggestions
Additional
Resources
--------------------------------------------------------------
The information presented on this site is intended to
assist pet owners in making intelligent decisions regarding
the use of Deramaxx®. It is not veterinary advice.
Owners need to work closely with their veterinarians in
deciding whether to use Deramaxx® and in treating
their companions if they experience an adverse reaction.
© Copyright 2003. Edward Murray. All
rights reserved.
Material on his site may be freely copied provided a link
is provided to the site.
